Abstract The disclosure describes new 4-aminoquinoline derivatives of general formula ##SPC1## And their acid addition salts, where X is a halogen atom or a trifluoromethyl group, Z is a hydrogen atom or a defined substituent, R is group of the formula --R.sub.3 N--A--NR.sub.1 R.sub.2 (II), ##SPC2## where A in formula II is a chain of 1 to 5 methylene groups which may be substituted with alkyl, the ring in formula IIIa and IIIb is a piperidine or pyrrolidine ring that may be substituted with alkyl and R 1 , R 2 and R 3 represent hydrogen or certain defined substituents. The new 4-aminoquinoline derivatives show anti-malarial activity and, in some cases, show one or more of the following activities:- anti-inflammatory activity, anti-hypertensive activity, anti-trichomonal activity, inhibition of blood platelet aggregation, anti-ulcer activity and activity against allergic asthma. Compounds where --COR is in the o-position with respect to the 7-(halo or trifluoromethyl)-4-quinolylamino group and R is di(lower alkyl)aminopiperidino or --NR 10 R 11 where R 10 is hydrogen or lower alkyl and R 11 is di(lower alkyl)amino(lower alkyl) or 1-(lower alkyl)piperidyl show anti-inflammatory activity.
A compound selected from those having the formula ##SPC16## and their pharmaceutically acceptable acid addition salts, wherein X is selected from halogen and trifluoromethyl; Z is selected from the group consisting of hydrogen, halogen and lower alkyl; and R is selected from di(lower alkyl)aminopiperidino and a group having the formula ##EQU3## wherein R 10 is selected from hydrogen and lower alkyl and R 11 is selected from di(lower alkyl)amino(lower alkyl) and 1-(lower alkyl)piperidinyl.
Claim 2
Dependent Claim
73 words
A compound selected from those having the formula ##SPC16## and their pharmaceutically acceptable acid addition salts, wherein X is selected from halogen and trifluoromethyl; Z is selected from the group consisting of hydrogen, halogen and lower alkyl; and R is selected from di(lower alkyl)aminopiperidino and a group having the formula ##EQU3## wherein R 10 is selected from hydrogen and lower alkyl and R 11 is selected from di(lower alkyl)amino(lower alkyl) and 1-(lower alkyl)piperidinyl.
Claim 3
Dependent Claim
20 words
A compound as defined in claim 1 which is selected from 2-(7-chloro-4-quinolylamino)-N-(1-ethyl-3-piperidyl)benzamide and the pharmaceutically acceptable acid addition salts thereof.
Claim 4
Dependent Claim
20 words
A compound as defined in claim 1 which is selected from 2-(7-chloro-4-quinolylamino)-N-(2-diethylaminoethyl)-N-ethylbenzamide and the pharmaceutically acceptable acid addition salts thereof.
Claim 5
Dependent Claim
20 words
A compound as defined in claim 1 which is selected from 2-(7-chloro-4-quinolylamino)-N-(2-diethylaminoethyl)benzamide and the pharmaceutically acceptable acid addition salts thereof.